Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-09-10

Clinical Trial Update: Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial investigating aflibercept with micropulse laser for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aflibercept (Aflibercept)

Snippet

Sponsor: Keyvan Koushan | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: COMPLETED